Our Focus

Three Pillars of Impact

Advancing policy advocacy, clinician education, and safety standards to protect patient access and elevate the field.

01

Policy Advocacy

Engaging directly with legislators, regulators, and federal agencies to shape a fair, science-driven regulatory framework that protects patient access while holding the field to the highest standards.

  • FDA & DEA engagement
  • State pharmacy board relations
  • Congressional outreach
  • Public comment submissions
02

Education & Credentialing

Developing and credentialing clinicians through the PepMed certification program, ensuring practitioners have the clinical knowledge to prescribe responsibly and safely.

  • PepMed certification program
  • CE credit eligibility
  • Academic partnerships
  • Continuous education
03

Legitimacy & Safety

Setting standards that span the entire ecosystem, from compounding pharmacy manufacturing practices and quality controls to clinician prescribing protocols and patient safety.

  • Compounding pharmacy standards
  • Clinician prescribing protocols
  • Patient safety frameworks
  • Informed consent guidelines
Flagship Event

Annual Conference - Washington, D.C.

Each September, AAPM convenes clinicians, researchers, and policymakers for scientific programming, peer exchange, and direct policy engagement in the nation's capital.

Learn More
Researcher examining peptide compounds in a modern pharmaceutical laboratory
Why It Matters

Why AAPM Matters

The credibility and leadership behind the Academy

Our founding advisory board includes former governors from both Republican and Democratic administrations, signaling that patient access to safe peptide medicine transcends party lines.

Board members include leading FDA regulatory attorneys, pharmacy law experts, and former state officials with deep experience in healthcare policy and compliance.

AAPM brings together physicians, researchers, pharmacists, and policymakers under one professional society to advocate for fair, science-driven oversight of peptide therapies. Our annual Washington D.C. conference each September convenes the field for scientific programming, peer exchange, and direct policy engagement.